Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
NVRO

NVRO - Nevro Corp Stock Price, Fair Value and News

9.25USD-0.20 (-2.12%)Market Closed

Market Summary

NVRO
USD9.25-0.20
Market Closed
-2.12%

NVRO Alerts

  • Losses in recent quarter

NVRO Stock Price

View Fullscreen

NVRO RSI Chart

NVRO Valuation

Market Cap

339.7M

Price/Earnings (Trailing)

-4.11

Price/Sales (Trailing)

0.79

EV/EBITDA

-6.83

Price/Free Cashflow

-4.79

NVRO Price/Sales (Trailing)

NVRO Profitability

Operating Margin

76.19%

EBT Margin

-20.47%

Return on Equity

-29.65%

Return on Assets

-13.86%

Free Cashflow Yield

-20.89%

NVRO Fundamentals

NVRO Revenue

Revenue (TTM)

430.7M

Rev. Growth (Yr)

5.78%

Rev. Growth (Qtr)

-12.29%

NVRO Earnings

Earnings (TTM)

-82.6M

Earnings Growth (Yr)

27.46%

Earnings Growth (Qtr)

-182.92%

Breaking Down NVRO Revenue

Last 7 days

1.7%

Last 30 days

-7.5%

Last 90 days

-32.2%

Trailing 12 Months

-60.6%

How does NVRO drawdown profile look like?

NVRO Financial Health

Current Ratio

7.38

Debt/Equity

0.77

Debt/Cashflow

-0.29

NVRO Investor Care

Shares Dilution (1Y)

2.54%

Diluted EPS (TTM)

-2.28

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024430.7M000
2023414.9M419.4M422.8M425.2M
2022386.1M388.0M395.3M406.4M
2021363.2M409.1M393.9M386.9M
2020395.6M358.4M366.7M362.0M
2019381.8M379.3M383.8M390.3M
2018345.9M363.9M377.3M387.3M
2017255.3M277.9M299.2M326.7M
2016101.6M145.6M191.1M228.5M
201535.6M39.5M46.2M69.6M
201424.8M26.6M29.1M32.6M
201319.5M20.8M22.2M23.5M
201200018.1M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Nevro Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jun 07, 2024
rashid kashif
sold (taxes)
-16,305
9.27
-1,759
svp, corp dev and clo
Jun 07, 2024
christoforou christofer
sold (taxes)
-12,227
9.27
-1,319
svp, chief operating officer
Jun 07, 2024
macleod roderick h.
sold (taxes)
-16,305
9.27
-1,759
svp, chief financial officer
Jun 03, 2024
grossman d keith
sold (taxes)
-10,580
9.33
-1,134
-
May 28, 2024
macleod roderick h.
sold (taxes)
-7,768
9.52
-816
svp, chief financial officer
May 28, 2024
christoforou christofer
sold (taxes)
-5,550
9.52
-583
svp, chief operating officer
May 28, 2024
rashid kashif
sold (taxes)
-7,777
9.52
-817
svp, corp dev and clo
May 23, 2024
grossman d keith
acquired
-
-
19,169
-
May 23, 2024
demane michael f
acquired
-
-
19,169
-
May 23, 2024
siegel susan e
acquired
-
-
19,169
-

1–10 of 50

Which funds bought or sold NVRO recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Jun 11, 2024
EverSource Wealth Advisors, LLC
new
-
116
116
-%
May 16, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-13.29
-342,061
475,957
-%
May 16, 2024
JANE STREET GROUP, LLC
reduced
-12.68
-1,754,830
2,482,930
-%
May 16, 2024
COMERICA BANK
sold off
-100
-280
-
-%
May 15, 2024
AQR CAPITAL MANAGEMENT LLC
sold off
-100
-256,583
-
-%
May 15, 2024
Rock Springs Capital Management LP
added
3.9
-6,679,400
15,378,600
0.39%
May 15, 2024
GOLDMAN SACHS GROUP INC
reduced
-26.76
-11,469,800
11,083,700
-%
May 15, 2024
Point72 Asia (Singapore) Pte. Ltd.
new
-
94,770
94,770
0.03%
May 15, 2024
Royal Bank of Canada
reduced
-85.05
-250,000
29,000
-%
May 15, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
new
-
175,229
175,229
-%

1–10 of 40

Are Funds Buying or Selling NVRO?

Are funds buying NVRO calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own NVRO
No. of Funds

Unveiling Nevro Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 21, 2024
engaged capital llc
6.0%
2,168,163
SC 13D/A
Feb 14, 2024
armistice capital, llc
8.76%
3,176,000
SC 13G
Feb 14, 2024
arrowmark colorado holdings llc
8.30%
3,011,059
SC 13G
Feb 14, 2024
alger associates inc
5.8%
2,115,664
SC 13G
Feb 13, 2024
vanguard group inc
11.23%
4,067,271
SC 13G/A
Jan 24, 2024
blackrock inc.
9.3%
3,374,031
SC 13G/A
Dec 11, 2023
engaged capital llc
6.0%
2,168,163
SC 13D
Sep 11, 2023
fmr llc
-
0
SC 13G/A
Jun 12, 2023
fmr llc
-
0
SC 13G/A
Feb 14, 2023
price t rowe associates inc /md/
0.7%
280,434
SC 13G/A

Recent SEC filings of Nevro Corp

View All Filings
Date Filed Form Type Document
Jun 11, 2024
4
Insider Trading
Jun 11, 2024
4
Insider Trading
Jun 11, 2024
4
Insider Trading
Jun 05, 2024
4
Insider Trading
May 30, 2024
4
Insider Trading
May 30, 2024
4
Insider Trading
May 30, 2024
4
Insider Trading
May 30, 2024
SD
SD
May 29, 2024
8-K
Current Report
May 28, 2024
4
Insider Trading

Peers (Alternatives to Nevro Corp)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
180.0B
40.3B
-0.37% 2.47%
31.97
4.46
-2.84% -3.00%
67.0B
19.7B
-1.25% -6.96%
50.29
3.4
4.82% -17.56%
20.4B
3.9B
-2.42% -17.36%
44.2
5.22
5.72% 46.72%
17.2B
14.9B
-5.98% -23.37%
6.49
1.15
2.98% 207.68%
MID-CAP
9.7B
3.5B
-1.37% 26.59%
30.88
2.73
6.16% 35.06%
8.5B
12.4B
-9.19% -12.63%
21.86
0.68
-0.93% -18.83%
8.0B
2.6B
-0.75% -24.43%
-24.93
3.09
-6.25% -68.58%
5.5B
3.9B
-4.01% -30.77%
-58.03
1.41
0.23% 90.80%
3.4B
387.1M
-0.49% 33.89%
-215.53
8.87
30.82% 65.57%
2.0B
6.6B
-10.56% -17.38%
10.59
0.31
2.78% -0.87%
SMALL-CAP
1.5B
3.2B
21.26% 13.50%
-2.22
0.48
7.94% -1695.32%
385.1M
169.3M
2.11% -4.54%
-5.01
2.28
7.49% -244.90%
248.7M
324.0M
0.33% -43.67%
-1.29
0.77
-3.19% -337.41%
50.6M
50.5M
8.39% -77.60%
-2.22
1
14.25% -10.06%
1.8M
3.7M
-47.47% -84.71%
-0.15
0.49
5.77% 8.23%

Nevro Corp News

Latest updates
MarketBeat47 hours ago
Yahoo Finance04 Jun 202404:37 pm
Yahoo Finance03 Jun 202407:00 am
Seeking Alpha08 May 202407:00 am
PR Newswire07 May 202407:00 am
The Motley Fool3 months ago

Nevro Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue-12.3%101,899,000116,176,000103,862,000108,809,00096,327,000113,844,000100,466,000104,213,00087,842,000102,760,00093,205,000102,330,00088,610,000109,731,000108,460,00056,390,00087,467,000114,374,000100,162,00093,571,00082,148,000
Gross Profit-12.2%71,528,00081,477,00069,516,00074,443,00064,624,00075,239,00069,302,00072,734,00059,092,00069,132,00064,630,00069,986,00062,294,00078,028,00076,077,00035,250,00060,547,00081,258,00069,940,00063,943,00053,209,000
Operating Expenses-107,362,000-95,075,000100,082,000100,947,00094,597,000-12,780,00096,525,00091,861,00095,347,000111,074,00085,749,00084,806,00078,903,00079,626,00070,611,00083,614,00092,939,00085,924,00090,503,00095,463,000
  S&GA Expenses9.6%88,326,00080,598,00081,152,00086,762,00086,192,00080,650,00078,190,00083,973,00079,325,00082,638,00079,521,00073,880,00073,272,00067,073,00068,512,00060,167,00071,402,00076,006,00072,905,00075,573,00081,328,000
  R&D Expenses19.4%14,828,00012,420,00013,923,00013,320,00014,755,00013,947,00014,030,00012,552,00012,536,00012,709,00011,553,00011,869,00011,534,00011,830,00011,114,00010,444,00012,212,00016,933,00013,019,00014,930,00014,135,000
EBITDA Margin19.2%-0.16-0.20-0.210.040.040.040.02-0.32-0.30-0.27-0.20-0.09---------
Interest Expenses105.8%6,512,0003,165,0001,618,0001,618,0001,613,0001,613,0001,608,0001,608,0001,603,0003,810,0003,688,0005,704,0006,547,0006,495,0006,363,0006,122,0002,826,0002,778,0002,755,0002,710,0002,688,000
Income Taxes105.8%382,000-6,578,000130,000477,000325,000356,000485,000241,000181,000-78,00072,000198,000342,000310,000208,00044,000306,000481,000420,000358,000340,000
Earnings Before Taxes-60.9%-25,027,000-15,559,000-23,349,000-24,247,000-34,704,000-18,836,00081,993,000-24,749,000-34,144,000-30,212,000-50,003,000-21,392,000-29,219,000-6,819,000-9,777,000-41,019,000-24,582,000-13,261,000-17,427,000-27,663,000-43,736,000
EBT Margin11.1%-0.20-0.23-0.240.010.010.01-0.02-0.36-0.35-0.34-0.27-0.16---------
Net Income-182.9%-25,409,000-8,981,000-23,479,000-24,724,000-35,029,000-19,192,00081,508,000-24,990,000-34,325,000-30,134,000-50,075,000-21,590,000-29,561,000-7,129,000-9,985,000-41,063,000-24,888,000-13,742,000-17,847,000-28,021,000-44,076,000
Net Income Margin11.6%-0.19-0.22-0.240.010.010.01-0.02-0.36-0.35-0.34-0.28-0.17---------
Free Cashflow-228.7%-35,449,000-10,785,000-8,026,000-16,710,000-31,902,000-15,810,00077,237,000-14,269,000-30,025,000-16,889,000-19,037,000-8,869,000---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets-6.2%596636562570574602606524533575582600776789778753460470448448458
  Current Assets-7.2%493531522531535563566483490531539557739753742717414422401401410
    Cash Equivalents-13.4%90.0010465.0065.0064.0012013110949.0035.0081.0014687.0045.0011927713665.0049.0063.0041.00
  Inventory1.8%12111912212011310099.0094.0091.0094.0092.0086.0086.0083.0084.0092.0093.0092.0091.0092.0093.00
  Net PPE0.6%25.0025.0024.0024.0023.0022.0021.0021.0021.0021.0020.0019.0015.0014.0012.0011.0011.0012.0012.0012.0012.00
  Goodwill0.4%38.0038.00-------------------
Liabilities-7.3%318343276275273279281294292271263241409401399379245253250246244
  Current Liabilities-19.9%67.0083.0080.0078.0075.0079.0080.0073.0070.0082.0075.0074.0024623923922161.0071.0068.0066.0065.00
  Short Term Borrowings-------------171169167164-----
  Long Term Debt1.6%21521118818718718718718618634.00149146144142140137162160158156154
    LT Debt, Non Current1.6%21521118818718718718718618634.00149146144142140137162160158156154
Shareholder's Equity-5.0%279293286295301324325230240304319358366388380374215216198202214
  Retained Earnings-3.6%-724-699-690-666-642-607-588-669-644-624-594-544-522-492-485-475-434-409-396-378-350
  Additional Paid-In Capital1.2%1,004993978964945934918903886928913902888881865851651626595580565
Shares Outstanding0.9%37.0036.0036.0036.0036.0036.0035.0035.0035.0035.0035.0035.00---------
Float----896---1,521---5,695---4,009---1,923-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-266.0%-32,656-8,923-6,090-14,502-29,314-13,42379,350-12,834-28,418-15,159-15,362-4,489-6,87111,85911,336-16,823-5,181-13,475-3,373-11,670-21,707
  Share Based Compensation-5.7%12,83713,61713,52316,16613,56014,80715,20613,37713,40811,45912,63711,0349,23710,11813,96510,0838,48910,38211,1929,72110,402
Cashflow From Investing2375.1%25,322-1,1137,28311,274-24,648458-56,50470,26950,067-34,232-48,185233,79050,342-92,111-170,131-167,92060,2947,646-12,53827,8819,341
Cashflow From Financing-113.3%-6,48048,698-1,0134,122-2,2731,37437.002,885-6,7533,276-1,325-169,862-1,4705,139761324,82716,17821,3893,0095,9211,774
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

NVRO Income Statement

2024-03-31
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]  
Revenue$ 101,899$ 96,327
Cost of revenue[1]30,37131,703
Gross profit71,52864,624
Operating expenses  
Research and development14,82814,755
Sales, general and administrative88,32686,192
Amortization of intangibles737 
Change in fair value of contingent consideration3,471 
Total operating expenses107,362100,947
Income (Loss) from operations(35,834)(36,323)
Interest income3,7803,278
Interest expense(6,512)(1,613)
Change in fair market value of warrants13,560 
Other income (expense), net(21)(46)
Loss before income taxes(25,027)(34,704)
Provision for income taxes382325
Net loss(25,409)(35,029)
Other comprehensive income (loss):  
Changes in foreign currency translation adjustment(255)506
Changes in unrealized gains on short-term investments, net(526)587
Net change in other comprehensive income (loss)(781)1,093
Comprehensive loss$ (26,190)$ (33,936)
Net loss per share, basic$ (0.7)$ (0.98)
Net loss per share, diluted$ (0.7)$ (0.98)
Weighted average number of shares used to compute basic net loss per share36,467,37135,584,685
Weighted average number of shares used to compute diluted net loss per share36,467,37135,584,685
[1]Exclusive of amortization of intangible assets, which is shown separately.

NVRO Balance Sheet

2024-03-31
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets  
Cash and cash equivalents$ 90,303$ 104,217
Short-term investments191,180218,506
Accounts receivable, net of allowance for doubtful accounts of $1,128 and $1,048 at March 31, 2024 and December 31, 2023, respectively76,91879,377
Inventories120,789118,676
Prepaid expenses and other current assets13,41410,145
Total current assets492,604530,921
Property and equipment, net24,70824,568
Operating lease assets7,7648,944
Goodwill38,32438,164
Intangible assets, net26,61727,354
Other assets5,4275,156
Restricted cash606606
Total assets596,050635,713
Current liabilities  
Accounts payable21,20822,520
Accrued liabilities39,48645,297
Contingent liabilities, current portion2209,836
Other current liabilities5,8605,722
Total current liabilities66,77483,375
Long-term debt214,763211,471
Long-term operating lease liabilities3,1364,634
Contingent liabilities, non-current portion15,56412,257
Warrant liability15,17928,739
Other long-term liabilities2,0932,092
Total liabilities317,509342,568
Commitments and contingencies (Note 6)
Stockholders’ equity  
Preferred stock, $0.001 par value, 10,000,000 shares authorized at March 31, 2024 and December 31, 2023; zero shares issued and outstanding at March 31, 2024 and December 31, 2023
Common stock, $0.001 par value, 290,000,000 shares authorized at March 31,2024 and December 31, 2023; 37,369,746 and 37,044,390 shares issued at March 31, 2024 and December 31, 2023, respectively; 36,686,830 and 36,361,474 shares outstanding at March 31, 2024 and December 31, 2023, respectively3636
Additional paid-in capital1,004,348992,762
Accumulated other comprehensive income (loss)(1,024)(243)
Accumulated deficit(724,819)(699,410)
Total stockholders’ equity278,541293,145
Total liabilities and stockholders’ equity$ 596,050$ 635,713
NVRO
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation system for the treatment of chronic pain, as well as Senza II and Senza Omnia SCS systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company's Senza HFX iQ IPG system includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system. In addition, it offers surpass surgical and percutaneous leads. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.
 CEO
 WEBSITEhttps://nevro.com
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES1087

Nevro Corp Frequently Asked Questions


What is the ticker symbol for Nevro Corp? What does NVRO stand for in stocks?

NVRO is the stock ticker symbol of Nevro Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Nevro Corp (NVRO)?

As of Wed Jun 12 2024, market cap of Nevro Corp is 347.09 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NVRO stock?

You can check NVRO's fair value in chart for subscribers.

What is the fair value of NVRO stock?

You can check NVRO's fair value in chart for subscribers. The fair value of Nevro Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Nevro Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for NVRO so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Nevro Corp a good stock to buy?

The fair value guage provides a quick view whether NVRO is over valued or under valued. Whether Nevro Corp is cheap or expensive depends on the assumptions which impact Nevro Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NVRO.

What is Nevro Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Jun 12 2024, NVRO's PE ratio (Price to Earnings) is -4.2 and Price to Sales (PS) ratio is 0.81. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NVRO PE ratio will change depending on the future growth rate expectations of investors.